Key facts
- MedVasc’s last known valuation is $6.9M (May 2025).
- It has raised $5.0M; the latest was Later Stage VC ($2.6M) in Jan 2026.
- Notable investors include Life Science Invest, Medlim, Medtech4Health, SWElife, SmiLe Incubator — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for MedVasc
- ·The full record, as it builds
Funding rounds
No funding rounds for MedVasc are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MedVasc
Developer of a medical instrument designed to improve the anesthetic procedure when treating varicose veins. The company's device minimizes the pain when performing the treatment methods for treating varicose veins and delivers pain-free local anesthesia from within the vein, enabling clinicians to perform procedures without additional sedation and allowing patients to return home immediately after treatment.
- Sector
- Healthcare
- HQ
- Lund, Sweden
- Founded
- 2013
- Employees
- 4
- Website
- medvasc.se/
- Ownership
- Privately Held (backing)
MedVasc doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MedVasc shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MedVasc in its N-PORT filings yet. We sweep new filings monthly.